Close
Smartlab Europe
Inizio Ignite

Press Releases

Noble and Aptar Pharma Launch AdhereIT, a Connected Medical Device Solution for Disease Management Adherence and Onboarding Patients

Noble and Aptar Pharma are pleased to announce the launch of AdhereIT™ - a connected, intuitive and user-friendly onboarding solution for the growing number of patients with chronic conditions who use autoinjectors to administer their medications at home. AdhereIT™...

AirBridgeCargo delivers over 500,000 vials with human albumin

AirBridgeCargo Airlines (ABC), one of the leaders in transportation of temperature-sensitive shipments, has organized dedicated pharma charter flight from Leipzig (Germany) to Guangzhou (China) through Novosibirsk (Russia). ABC’s long-standing partner, Kuehne+Nagel, safely delivered 19 ULDs from Vienna (Austria) to the...

Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR -COV19 vaccine candidate

Recipharm, a leading contract development and manufacturing organisation (CDMO) has entered into an agreement with Arcturus Therapeutics, a leading U.S. based clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver...

Eisai enters joint research pact with four research organizations in Japan for development of therapeutics for novel COVID-19

Eisai Co Ltd announced that it has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global Health and Medicine, Nagasaki University, and Yokohama City University) in Japan concerning the “Development of...

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care Early) study evaluating VIR-7831 for the early treatment of COVID-19 in patients who are...

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2

Pfizer Inc. and BioNTech SE announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lead candidate from the companies’ vaccine development program against COVID-19. The EMA’s decision to start a rolling review...

TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement

TraceLink Inc., the leading digital platform company for the life sciences supply chain, announced that Henry Schein, the world's largest provider of health care solutions to office-based dental and medical practitioners, has implemented TraceLink's verification router service (VRS) solution....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »